10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Diagnostic Microbiology plays a pivotal role in the realm of antimicrobials, serving as a critical tool in identifying and managing infectious diseases. This field employs various techniques to isolate, identify, and characterize microorganisms, aiding clinicians in prescribing targeted antimicrobial therapies. From traditional culture methods to advanced molecular techniques, diagnostic microbiology enables the precise identification of pathogens and their susceptibility to antimicrobial agents. This information is instrumental in guiding healthcare professionals towards selecting the most effective treatments, minimizing the risk of antibiotic resistance and optimizing patient outcomes. Through continuous advancements, Diagnostic Microbiology contributes significantly to the ongoing battle against infectious diseases, ensuring a more nuanced and personalized approach to antimicrobial therapy.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria